RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: alcohol use disorder
Accession: DOID:1574
browse the term
Definition: A substance abuse that involves the recurring use of alcoholic beverages despite negative consequences. (DO)
Synonyms: exact_synonym: alcohol abuse; chronic alcoholic intoxication; ethanol abuse
related_synonym: Beta-glycopyranoside tasting
primary_id: MESH:D000437
xref: ICD10CM:F10.1 ; ICD9CM:305.0 ; NCI:C20701
For additional species annotation, visit the
Alliance of Genome Resources .
G
Acads
acyl-Coenzyme A dehydrogenase, short chain
susceptibility
ISO
DNA:SNP:: (rs1799958) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 5:115,248,358...115,257,405
Ensembl chr 5:115,248,358...115,257,405
G
Adh1
alcohol dehydrogenase 1 (class I)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16404797
NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
G
Adh5
alcohol dehydrogenase 5 (class III), chi polypeptide
ISO
RGD
PMID:8462548
RGD:5129091
NCBI chr 3:138,142,961...138,161,260
Ensembl chr 3:138,148,854...138,161,260
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16404797 PMID:17590986 PMID:10780266
RGD:734551
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Ankk1
ankyrin repeat and kinase domain containing 1
severity
ISO
DNA:polymorphism: :rs1800497(human) DNA:SNP,haplotype: :rs11604671, rs4938015 (human)
RGD
PMID:32889058 PMID:21936764
RGD:401940151 , RGD:401959296
NCBI chr 9:49,326,494...49,338,341
Ensembl chr 9:49,326,494...49,338,321
G
Arc
activity regulated cytoskeletal-associated protein
IDA
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr15:74,540,930...74,544,419
Ensembl chr15:74,540,932...74,544,419
G
Bdnf
brain derived neurotrophic factor
ISO IEP
protein:decreased expression:plasma protein:decreased expression:plasma (human) mRNA,protein:decreased expression:hippocampus, plasma (rat) mRNA:decreased expression:hippocampus protein:altered expression:brain protein:decreased expression:cerebellum, hippocampus
RGD
PMID:32135570 PMID:30277635 PMID:30277635 PMID:32497709 PMID:15307153 PMID:19100286 More...
RGD:35673317 , RGD:401938665 , RGD:401938665 , RGD:401950485 , RGD:401965482 , RGD:401976492
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Calb1
calbindin 1
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 4:15,881,264...15,906,709
Ensembl chr 4:15,881,264...15,908,064
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
IEP
mRNA:increased expression:prefrontal cortex
RGD
PMID:28714806
RGD:18337277
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
G
Camk4
calcium/calmodulin-dependent protein kinase IV
ISO
protein:decreased expression:brain, cingulate gyrus
RGD
PMID:11181917
RGD:401959326
NCBI chr18:33,067,995...33,328,820
Ensembl chr18:33,067,984...33,324,281
G
Cast
calpastatin
ISO
protein:increased expression:gastrocnemius (rat)
RGD
PMID:28800153
RGD:405100967
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
G
Cat
catalase
treatment
ISO
associated with diabetes;protein:decreased activity:liver, kidney (rat) associated with cognitive disorder; protein:altered activity:hippocampus (rat) associated with cardiomyopathy associated with diabetes; protein:decreased activity;testis, epididymis (rat)
RGD
PMID:22596042 PMID:21713042 PMID:27367870 PMID:7195942 PMID:25541261
RGD:405255659 , RGD:405255660 , RGD:405255662 , RGD:405255663 , RGD:405255664
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cckar
cholecystokinin A receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9922984
NCBI chr 5:53,855,827...53,865,046
Ensembl chr 5:53,855,118...53,865,047
G
Cdk20
cyclin dependent kinase 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr13:64,580,133...64,587,536
Ensembl chr13:64,580,128...64,589,587
G
Chrna3
cholinergic receptor, nicotinic, alpha polypeptide 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846
G
Chrna5
cholinergic receptor, nicotinic, alpha polypeptide 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr 9:54,888,112...54,918,704
Ensembl chr 9:54,888,164...54,915,063
G
Clock
clock circadian regulator
susceptibility
ISO
DNA:SNP:: (rs2412648) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 5:76,357,715...76,452,675
Ensembl chr 5:76,357,715...76,452,639
G
Cnr1
cannabinoid receptor 1
sexual_dimorphism
ISO
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Comt
catechol-O-methyltransferase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:: DNA:polymorphism: :rs4680(human)
CTD RGD
PMID:10395222 PMID:10395222 PMID:32889058
RGD:401940114 , RGD:401940151
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Creb1
cAMP responsive element binding protein 1
sexual_dimorphism
ISO
mRNA, protein:decreased expression:amygdala protein:altered expression, altered phosphorylation:liver, nucleus protein:increased phosphorylation:liver
RGD
PMID:29991681 PMID:22269225 PMID:31262967
RGD:401938626 , RGD:401959317 , RGD:401959334
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Crebbp
CREB binding protein
ISO
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
G
Crh
corticotropin releasing hormone
ISO
mRNA:increased expression:central amygdaloid nucleus (rat)
RGD
PMID:20060104
RGD:5508173
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
G
Crhr1
corticotropin releasing hormone receptor 1
IMP
RGD
PMID:11988580
RGD:734822
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO IMP
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma, extracellular exosome
CTD RGD
PMID:20843640 PMID:29404485 PMID:29404485 PMID:23819932
RGD:14700911 , RGD:14700911 , RGD:14700915
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Dbh
dopamine beta hydroxylase
no_association
ISO
DNA:polymorphism:cds:g.444G>A (human) DNA:polymorphism:5' utr:g.-1021C>T (human)
RGD
PMID:16252068 PMID:16133787
RGD:1625571 , RGD:1625572
NCBI chr 2:27,055,519...27,073,216
Ensembl chr 2:27,055,245...27,073,212
G
Dcx
doublecortin
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr X:142,638,838...142,716,392
Ensembl chr X:142,638,838...142,716,307
G
Dlg4
discs large MAGUK scaffold protein 4
IEP
associated with Prenatal Exposure Delayed Effects and anxiety disorder:mRNA,protein:decreased expression:brain (mouse)
RGD
PMID:30016666
RGD:401959614
NCBI chr11:69,908,029...69,938,107
Ensembl chr11:69,907,768...69,938,348
G
Drd2
dopamine receptor D2
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Drd4
dopamine receptor D4
treatment susceptibility
ISO
DNA:repeats:exon: associated with peer pressure;DNA:repeats:exon:
RGD
PMID:25640830 PMID:26307243
RGD:11064848 , RGD:401959598
NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
G
Ep300
E1A binding protein p300
ISO
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Ercc1
excision repair cross-complementing rodent repair deficiency, complementation group 1
ISO
RGD
PMID:23095216
RGD:10045658
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
G
Fmr1
fragile X messenger ribonucleoprotein 1
ISO
mRNA:increased expression:cerebellum
RGD
PMID:34453331
RGD:401938639
NCBI chr X:67,722,144...67,761,569
Ensembl chr X:67,722,147...67,761,569
G
Fos
FBJ osteosarcoma oncogene
treatment
ISO IEP
protein:increased expression:brain protein:increased expression:parvocellular oculomotor nucleus
RGD
PMID:14741756 PMID:11164784 PMID:29210146
RGD:405255650 , RGD:405255652 , RGD:405295495
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fosb
FBJ osteosarcoma oncogene B
treatment
ISO IEP
protein:increased expression:brain (mouse) protein:increased expression:dorsal striatum (mouse)
RGD
PMID:22792289 PMID:9835277 PMID:27380261
RGD:401851082 , RGD:401901184 , RGD:401901287
NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976
G
Fshb
follicle stimulating hormone beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr17:37,356,888...37,385,197
Ensembl chr17:37,356,858...37,385,959
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
susceptibility
ISO
DNA:SNP:intron: (rs2900512) (human)
RGD
PMID:28118741
RGD:401940105
NCBI chr 4:46,662,318...46,991,714
Ensembl chr 4:46,662,305...46,991,873
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
susceptibility
ISO
DNA:SNPs:multiple: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22253714 PMID:15024690
RGD:6480257
NCBI chr 5:71,115,735...71,253,192
Ensembl chr 5:71,114,940...71,253,192
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Gata4
GATA binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20585342
NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
G
Gdnf
glial cell line derived neurotrophic factor
ISO
protein:increased expression:serum DNA:hypomethylation:nucleus accumbens
RGD
PMID:25623403 PMID:31710958
RGD:401965480 , RGD:405820205
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12747453
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Ghsr
growth hormone secretagogue receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23977009
NCBI chr 3:27,425,500...27,433,384
Ensembl chr 3:27,425,500...27,432,159
G
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr12:78,264,099...78,731,546
Ensembl chr12:78,273,153...78,731,546
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
IEP ISO
protein:increased phosphorylation:lumbar spinal cord (mouse) protein:increased expression:nucleus accumbens (rat) protein:increased expression:nucleus accumbens (mouse) protein:increased expression, increased phosphorylation:cingulate cortex (rat) protein:decreased expression:neocortex (rat)
RGD
PMID:28585190 PMID:21041654 PMID:21041654 PMID:34280506 PMID:12036520
RGD:405100727 , RGD:405650686 , RGD:405650686 , RGD:405818275 , RGD:405820203
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
ISO
RGD
PMID:14573320
RGD:1642372
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
ISO
RGD
PMID:14573320 PMID:16911840
RGD:1642372 , RGD:1642200
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
Hdac2
histone deacetylase 2
ISO
RGD
PMID:23485013
RGD:9590265
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
treatment
ISO
RGD
PMID:9631953
RGD:401900760
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
Htr1b
5-hydroxytryptamine (serotonin) receptor 1B
sexual_dimorphism no_association onset
ISO
associated with attention deficit hyperactivity disorder;DNA:SNP: :rs11568817(human) DNA:SNPs: :multiples (human) DNA:SNP: :rs13212041 (human)
RGD
PMID:28923721 PMID:11496363 PMID:30774345
RGD:405650695 , RGD:405818272 , RGD:405847403
NCBI chr 9:81,510,344...81,515,885
Ensembl chr 9:81,510,344...81,515,881
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:cerebral cortex, liver protein:increased expression:dorsal raphe, nucleus accumbens
CTD RGD
PMID:20501057 PMID:9347075 PMID:9347073 PMID:9631953
RGD:401900301 , RGD:401900740 , RGD:401900742 , RGD:401900760
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Htr2c
5-hydroxytryptamine (serotonin) receptor 2C
treatment
ISO
RGD
PMID:24041931
RGD:401900761
NCBI chr X:145,745,509...145,980,273
Ensembl chr X:145,745,509...145,980,273
G
Htr3a
5-hydroxytryptamine (serotonin) receptor 3A
HDA
DNA:hypermethylation, hypomethylation:promoter: (mouse)
RGD
PMID:22834954
RGD:404976877
NCBI chr 9:48,810,513...48,822,451
Ensembl chr 9:48,810,513...48,822,399
G
Htr3b
5-hydroxytryptamine (serotonin) receptor 3B
susceptibility
ISO
DNA:SNP:cds:rs1176744(human)
RGD
PMID:20838391
RGD:6480660
NCBI chr 9:48,846,308...48,876,290
Ensembl chr 9:48,846,308...48,876,290
G
Htr7
5-hydroxytryptamine (serotonin) receptor 7
ISO
DNA:SNP:intron: (rs7916403) (human)
RGD
PMID:21184583
RGD:150429835
NCBI chr19:35,935,815...36,035,533
Ensembl chr19:35,936,134...36,034,907
G
Igf2
insulin-like growth factor 2
ISO
protein:decreased expression:plasma (human)
RGD
PMID:30277635
RGD:401938665
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Il10
interleukin 10
ISO
mRNA:increased expression:liver
RGD
PMID:22269225
RGD:401959317
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
ISO
DNA:SNP:promoter:rs2836016 (human)
RGD
PMID:21307845
RGD:6483053
NCBI chr16:94,545,839...94,798,719
Ensembl chr16:94,549,495...94,798,560
G
Lhb
luteinizing hormone beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
G
Maoa
monoamine oxidase A
susceptibility
ISO
RGD
PMID:15900229
RGD:1600720
NCBI chr X:16,485,937...16,554,051
Ensembl chr X:16,485,937...16,554,057
G
Mapk1
mitogen-activated protein kinase 1
ISO
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk14
mitogen-activated protein kinase 14
IDA
protein:increased expression, increased phosphorylation:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk3
mitogen-activated protein kinase 3
ISO
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
ISO
RGD
PMID:31262967
RGD:401959334
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mcm5
minichromosome maintenance complex component 5
ISO
RGD
PMID:23095216
RGD:10045658
NCBI chr 8:75,836,096...75,855,067
Ensembl chr 8:75,836,197...75,855,067
G
Mir191
microRNA 191
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 9:108,445,518...108,445,591
Ensembl chr 9:108,445,518...108,445,591
G
Mir195a
microRNA 195a
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr11:70,125,868...70,125,961
Ensembl chr11:70,125,868...70,125,961
G
Mir206
microRNA 206
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 1:20,749,234...20,749,306
Ensembl chr 1:20,749,234...20,749,306
G
Mir30a
microRNA 30a
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mki67
antigen identified by monoclonal antibody Ki 67
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mmp2
matrix metallopeptidase 2
ISO
RGD
PMID:24966898
RGD:13207311
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:24966898
RGD:13207311
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Ncam1
neural cell adhesion molecule 1
treatment sexual_dimorphism
ISO
mRNA:decreased expression:hippocampus (rat) associated with chronic stress in female rats
RGD
PMID:30277635 PMID:16207289 PMID:27894930
RGD:401938665 , RGD:401959613 , RGD:401959751
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
G
Ngf
nerve growth factor
ISO IEP
protein:increased expression:serum protein:decreased expression:brain protein:decreased expression:cerebral cortex, hippocampus
RGD
PMID:25623403 PMID:15307153 PMID:19100286
RGD:401965480 , RGD:401965482 , RGD:401976492
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Npy
neuropeptide Y
ISO
DNA:deletion:intron:g.4666_4674del (rat) DNA:missense mutation: :p.L7P (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17572454 PMID:15749341 PMID:12215082
RGD:1357412 , RGD:10430830
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Npy2r
neuropeptide Y receptor Y2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18828811
NCBI chr 3:82,445,688...82,455,404
Ensembl chr 3:82,445,690...82,455,391
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
treatment sexual_dimorphism
ISO
RGD
PMID:29437012 PMID:33007359 PMID:30171933
RGD:401965466 , RGD:401966865 , RGD:401976281
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
Nrg1
neuregulin 1
sexual_dimorphism
ISO
in female, associated with stressful life event;DNA:SNP: :rs6994992(human)
RGD
PMID:27353026
RGD:405100235
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Ntf3
neurotrophin 3
ISO
protein:decreased expression:plasma (human) mRNA,protein:decreased expression:hippocampus, plasma (rat) protein:increased expression:brain
RGD
PMID:30277635 PMID:30277635 PMID:15307153
RGD:401938665 , RGD:401938665 , RGD:401965482
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
IDA ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:protein:decreased acetylation:brain
RGD
PMID:30016666 PMID:8840027
RGD:401959614 , RGD:401965407
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Oprd1
opioid receptor, delta 1
ISO
associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat) DNA:SNPs, haplotype:intron 1:multiple (human)
RGD
PMID:28511993 PMID:7501658 PMID:24533225
RGD:401976432 , RGD:401976439 , RGD:402525443
NCBI chr 4:131,834,980...131,872,042
Ensembl chr 4:131,838,037...131,871,797
G
Oprk1
opioid receptor, kappa 1
severity no_association susceptibility
ISO
DNA:SNP, haplotype: :rs6473797 (human) DNA:SNP: :rs997917 (human) DNA:SNP: :rs6473797 (human) associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat)
RGD
PMID:31004399 PMID:37177778 PMID:37177778 PMID:28511993
RGD:401831037 , RGD:401850581 , RGD:401850581 , RGD:401976432
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
Oprl1
opioid receptor-like 1
ISO
RGD
PMID:11814626
RGD:9835016
NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
G
Oprm1
opioid receptor, mu 1
no_association treatment
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs510769 DNA:missense mutations, SNP:exon, intron:p.A6V, p.S147C, p.N40D (118A>G) (rs 1799971), IVS2+691G>C (human) DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human)
CTD RGD
PMID:12815747 PMID:26042510 PMID:9399694 PMID:32772383
RGD:401827930 , RGD:401827934 , RGD:401827947
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
Pde4b
phosphodiesterase 4B, cAMP specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
G
Pdyn
prodynorphin
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism associated with cocaine dependence;DNA, mRNA:SNPs, haplotype:3' utr:rs910080, rs910079, rs2235749 (human) DNA, mRNA:SNP, decreased expression:promoter, dorsolateral prefrontal cortex:rs1997794 (human) DNA:SNP: :rs2281285 (human) DNA:SNPs: :rs2281285, rs2225749, rs910080 (human) mRNA, protein:decreased expression:hippocampus, granule cell
CTD RGD
PMID:17559549 PMID:18923396 PMID:18923396 PMID:29925858 PMID:36099111 PMID:37177778 PMID:1589146 More...
RGD:401850550 , RGD:401850559 , RGD:401850566 , RGD:401850581 , RGD:401851059
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Penk
preproenkephalin
ISO
mRNA:increased expression:frontal lobe:
RGD
PMID:22703995
RGD:10003152
NCBI chr 4:4,133,536...4,138,815
Ensembl chr 4:4,133,531...4,138,819
G
Pomc
pro-opiomelanocortin-alpha
ISO
protein:decreased expression:brain (rat)
RGD
PMID:18162070
RGD:401976284
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Rpl18a
ribosomal protein L18A
ISO
mRNA:decreased expression:parietal cortex
RGD
PMID:11244494
RGD:11038708
NCBI chr 8:71,347,366...71,350,087
Ensembl chr 8:71,347,366...71,350,056
G
Shbg
sex hormone binding globulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
susceptibility
ISO
protein:decreased activity: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15520362 PMID:17000009 PMID:20838391
RGD:6480660
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Snca
synuclein, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18055133
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
Sod1
superoxide dismutase 1, soluble
ISO
associated with diabetes; protein:decreased activity;testis, epididymis (rat)
RGD
PMID:25541261
RGD:405255664
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sox2
SRY (sex determining region Y)-box 2
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
G
Spi1
Spi-1 proto-oncogene
treatment
ISO
protein:decreased expression:alveolar macrophage
RGD
PMID:16272341 PMID:21447000
RGD:9586723 , RGD:9586725
NCBI chr 2:90,912,750...90,946,104
Ensembl chr 2:90,912,735...90,946,101
G
Spn
sialophorin
IDA
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr 7:126,731,404...126,743,785
Ensembl chr 7:126,731,404...126,736,995
G
St6gal1
beta galactoside alpha 2,6 sialyltransferase 1
severity
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:17697868
RGD:10043133
NCBI chr16:23,043,478...23,179,100
Ensembl chr16:23,043,490...23,179,100
G
Syp
synaptophysin
sexual_dimorphism
ISO
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr X:7,504,819...7,519,495
Ensembl chr X:7,504,710...7,519,495
G
Tacr1
tachykinin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19204064
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
G
Tacr3
tachykinin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422838
NCBI chr 3:134,534,768...134,640,342
Ensembl chr 3:134,534,768...134,640,340
G
Tas2r118
taste receptor, type 2, member 118
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16385453 PMID:17250611
NCBI chr 6:23,969,160...23,970,059
Ensembl chr 6:23,969,160...23,970,059
G
Tas2r138
taste receptor, type 2, member 138
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17250611
NCBI chr 6:40,589,249...40,590,244
Ensembl chr 6:40,589,249...40,590,244
G
Tbx19
T-box 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 1:164,965,403...164,988,342
Ensembl chr 1:164,965,424...164,988,342
G
Timeless
timeless circadian clock 1
susceptibility
ISO
DNA:SNP:: (rs2291738) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr10:128,067,932...128,088,810
Ensembl chr10:128,067,934...128,088,810
G
Tph1
tryptophan hydroxylase 1
ISO
RGD
PMID:15654285
RGD:1580464
NCBI chr 7:46,294,065...46,321,961
Ensembl chr 7:46,294,065...46,321,961
G
Trf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11000917 PMID:21792595
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Vip
vasoactive intestinal polypeptide
susceptibility
ISO
DNA:SNPs, haplotype:: (rs3823082,rs688136) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all